Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Daily News

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

L.A. McKeown

September 12, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2019

Caitlin E. Cox

May 31, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Caitlin E. Cox

June 28, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

Presentation TCT 2013

Long term effect of transcatheter intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia

Presenter: Jean-Claude Lubanda, Miroslav Chochola, Robert Pytlik, Ales Linhart

January 31, 2013

News Daily News

Los Expertos Eligen los Avances Más Importantes de 2011

Jason Kahn

March 08, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

Advertisement

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

July 2024 Dispatch for the CV Team

May 2024 Dispatch for the CV Team

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

September 2022 News Roundup

December 2021 News Roundup

September 2021 News Roundup

TCTMD’s Top 10 Most Popular Stories for May 2019

TCTMD’s Top 10 Most Popular Stories for January 2019

Next-Generation Large-Bore Closure Devices Arrive

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

Long term effect of transcatheter intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia

Los Expertos Eligen los Avances Más Importantes de 2011

Experts Give Their Picks for Most Important Developments of 2011

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content